IDEXX Laboratories, Inc. (IDXX)
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.
Why Is Idexx (IDXX) Down 0.4% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Should You Add IDEXX Stock to Your Portfolio Right Now?
IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
IDEXX Gains 56.2% in a Year: What's Driving the Rally?
IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes
Major U.S. equities indexes pushed higher at the top of the new trading week, bouncing back from declines posted ahead of the weekend. Although weaker-than-expected jobs data released on Friday raised concerns about the resilience of the economy, the slowdown in hiring and uptick in unemployment could add to the case for upcoming interest-rate cuts by the Federal Reserve.
IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jonathan J. Mazelsky - President, CEO & Director Conference Call Participants Christopher Thomas Schott - JPMorgan Chase & Co, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division David Michael Westenberg - Piper Sandler & Co., Research Division Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division Jonathan David Block - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Leonidovich Ryskin - BofA Securities, Research Division Navann Ty Dietschi - BNP Paribas Exane, Research Division Ryan Scott Daniels - William Blair & Company L.L.C.
